cryptotanshinone has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, W; Liu, T; Luo, F; Shi, G; Wu, Y; Zhang, H; Zhang, L; Zhang, Y | 1 |
1 other study(ies) available for cryptotanshinone and Cardiovascular Diseases
| Article | Year |
|---|---|
Cryptotanshinone ameliorates cardiac injury and cardiomyocyte apoptosis in rats with coronary microembolization.
Topics: Administration, Oral; Animals; Apoptosis; Cardiovascular Diseases; Disease Models, Animal; Embolism; Male; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; Phenanthrenes; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |